Microbot Medical Inc.

Microbot Medical Inc. is a development-stage medical device company focused on robotic-assisted endovascular surgery. Its core effort is the LIBERTY® Endovascular Robotic Surgical System, a platform intended to help physicians perform vascular procedures with remote robotic control and improved precision.

23.33

23.16

— Microbot Medical Inc.
%
Robotic endovascular system0% The LIBERTY® platform and related robotic hardware/software for minimally invasive vascular procedures.
Product development and prototyping60% Engineering, prototype materials, and research studies used to advance the device pipeline.
Regulatory and commercialization preparation25% Activities supporting clinical, regulatory, and market launch readiness for the system.
Intellectual property and portfolio maintenance15% Patent portfolio work and related development-stage support costs tied to the platform.

Microbot is not yet generating revenue, so it does not have a broad commercial customer base today...

  • Hospitals and health systemsprimary

    Future purchasers of the LIBERTY system for vascular procedure rooms and interventional suites.

  • Interventional physiciansprimary

    Clinical users who would adopt the platform to improve control, precision, and ergonomics.

  • Government grant agenciessecondary

    Public funding sources such as the Israeli Innovation Authority that support R&D.

  • Equity and debt investorsprimary

    Capital providers that fund operations until product commercialization generates revenue.

Microbot is headquartered in the United States but has meaningful operational exposure to Israel through its office,...

  • •United States headquarters and public-company base
  • •Israel-based office and supply chain support activities
  • •Israeli subcontractors and vendors support development work
  • •Cross-border shipping and import logistics matter for device buildout
  • •No operating revenue disclosed yet, so market mix is not available

Microbot’s near-term strategy is to fund and complete commercialization of the LIBERTY® Endovascular Robotic Surgical...

01
Commercialize LIBERTY® Endovascular Robotic Surgical Systemshort-term

The company needs product launch success to transition from development-stage funding to operating revenue.

02
Raise additional capital as neededshort-term

Microbot currently relies on external financing to fund operations and development.

03
Develop future versions and applicationsmedium-term

Pipeline expansion can extend the platform beyond the initial product and broaden market opportunity.

Microbot remains a pre-revenue company, so its business model depends on successful product development, regulatory...

high

Financing dependence and dilution

The company has not generated revenue and must fund commercialization through equity, debt, and option exercises.

Scope
Ongoing operating and commercialization funding
Materiality
high
high

Israel geopolitical and logistics disruption

Israeli subcontractors, vendors, flights, and import/shipping channels can be disrupted by military activity.

Scope
Clinical, regulatory, and device-build support activities
Materiality
high
high

Commercialization execution risk

The company must convert a development-stage product into a marketable system with regulatory and adoption milestones.

Scope
LIBERTY launch and future product versions
Materiality
high
high

Ongoing losses and cash burn

R&D, public-company, and commercialization costs continue before revenue generation begins.

Scope
Operating cash flow and liquidity
Materiality
high
Research and development expense recognition
Affects operating loss and cash burn visibility
Government grants and royalty obligations
Affects net R&D expense and future gross margin economics
Fair value of financial instruments
Can affect earnings and balance sheet values
Equity and preferred investment option exercises
Affects dilution, cash resources, and per-share metrics
Income tax valuation on net operating losses
Limits deferred tax asset recognition

ENvue Medical, Inc.

FEED · Orthopedic, Prosthetic & Surgical Appliances & Supplies

MICROVISION, INC.

MVIS · Electronic Components, NEC

STRYKER CORP

SYK · Surgical & Medical Instruments & Apparatus

GBT Technologies Inc.

GTCH · Services-Management Consulting Services

MERIT MEDICAL SYSTEMS INC

MMSI · Surgical & Medical Instruments & Apparatus

IR-Med, Inc.

Electromedical & Electrotherapeutic Apparatus

: 28/04/2026